本页面由Tiger Trade Technology Pte. Ltd.提供服务

BioCryst制药

8.36
-0.1900-2.22%
盘后:8.420.0600+0.72%19:30 EDT
成交量:346.69万
成交额:2,899.24万
市值:21.36亿
市盈率:-5.55
高:8.55
开:8.49
低:8.24
收:8.55
52周最高:11.22
52周最低:6.00
股本:2.56亿
流通股本:2.22亿
量比:0.82
换手率:1.56%
股息:- -
股息率:- -
每股收益(TTM):-1.5054
每股收益(LYR):1.21
净资产收益率:587.33%
总资产收益率:52.86%
市净率:-4.70
市盈率(LYR):6.91

数据加载中...

2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/08/04

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/06/29

重要事件披露

Form 8-K - Current report
2026/06/12

重要事件披露

Form 8-K - Current report
2026/05/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/12

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/05/04

重要事件披露

Form 8-K - Current report
2026/04/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report